Literature DB >> 30878125

Early colorectal cancer: diagnosis, treatment and survivorship care.

Gabriella Buccafusca1, Ilaria Proserpio2, Antonino Carmelo Tralongo2, Sebastiano Rametta Giuliano1, Paolo Tralongo3.   

Abstract

CRC is the third most commonly diagnosed malignancy and the fourth leading cause of cancer-related death in the world. With advances in treatment, colorectal cancer is being transformed from a deadly disease to an illness that is increasingly curable. With this transformation has come increased interest in the unique problems, risks, needs, and concerns of survivors who have completed treatment and are cancer-free. They often suffer late/long-term side effects of therapies that may compromise their QoL such as fatigue, sleep difficulty, fear of recurrence, anxiety, depression, negative body image, sensory neuropathy, gastrointestinal problems, urinary incontinence, and sexual dysfunction. In this review, we discuss what is known about early colorectal diagnosis, staging, treatments and their long-term effects on quality of life and survivorship care.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Cancer survivors; Cured; Life-style; late/long term side effects

Mesh:

Year:  2019        PMID: 30878125     DOI: 10.1016/j.critrevonc.2019.01.023

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  36 in total

1.  Bioinformatics Analysis of Prognosis-Related Genes and Expression of CXCL8 in Colorectal Cancer.

Authors:  Zhen Yao; Xue Pan; Wenyue Chen; Yongjian Pei; Chen Chen; Yongkang Huang; Songtao Liu; Yulong Liu
Journal:  Biomed Res Int       Date:  2022-07-06       Impact factor: 3.246

2.  Assessing Ethnic Inequalities in Diagnostic Interval of Common Cancers: A Population-Based UK Cohort Study.

Authors:  Tanimola Martins; Gary Abel; Obioha C Ukoumunne; Sarah Price; Georgios Lyratzopoulos; Frank Chinegwundoh; William Hamilton
Journal:  Cancers (Basel)       Date:  2022-06-23       Impact factor: 6.575

3.  A real world analysis of recurrence risk factors for early colorectal cancer T1 treated with standard endoscopic resection.

Authors:  C Martínez Vila; H Oliveres Montero de Novoa; E Martínez-Bauer; X Serra-Aracil; L Mora; A Casalots-Casado; I Macías-Declara; C Pericay
Journal:  Int J Colorectal Dis       Date:  2020-03-07       Impact factor: 2.571

4.  Food Insecurity Is an Independent Risk Factor for Depressive Symptoms in Survivors of Digestive Cancers.

Authors:  Katelyn E Madigan; David A Leiman; Deepak Palakshappa
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-04-13       Impact factor: 4.254

5.  The role of folate receptor-positive circulating tumor cell analysis in the diagnosis of colorectal cancer: a retrospective cohort study.

Authors:  Su Yan; Wenyi Guo; Yanliang Liu; Kai Li; Weixing Wang
Journal:  Int J Clin Oncol       Date:  2022-01-19       Impact factor: 3.402

Review 6.  Frailty and long-term survival of patients with colorectal cancer: a meta-analysis.

Authors:  Suhua Chen; Tianjiang Ma; Wei Cui; Taowei Li; Duoping Liu; Lang Chen; Guoyao Zhang; Lei Zhang; Yali Fu
Journal:  Aging Clin Exp Res       Date:  2022-02-01       Impact factor: 3.636

7.  Fertility Preservation Discussions Between Young Adult Rectal Cancer Survivors and Their Providers: Sex-Specific Prevalence and Correlates.

Authors:  Julia Stal; Serena Y Yi; Sally Cohen-Cutler; Phuong Gallagher; Afsaneh Barzi; David R Freyer; Joel E Milam; Heinz-Josef Lenz; Kimberly A Miller
Journal:  Oncologist       Date:  2022-07-05       Impact factor: 5.837

8.  The circular RNA circSPARC enhances the migration and proliferation of colorectal cancer by regulating the JAK/STAT pathway.

Authors:  Jiaqi Wang; Yi Zhang; Hu Song; Hang Yin; Tao Jiang; Yixin Xu; Lianyu Liu; Hongyu Wang; Hong Gao; Renhao Wang; Jun Song
Journal:  Mol Cancer       Date:  2021-06-01       Impact factor: 27.401

9.  Low expression of adenomatous polyposis coli 2 correlates with aggressive features and poor prognosis in colorectal cancer.

Authors:  Yan Sun; Hua Tian; Xuehu Xu; Lin Wang
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

10.  Evidence That Tumor Microenvironment Initiates Epithelial-To-Mesenchymal Transition and Calebin A can Suppress it in Colorectal Cancer Cells.

Authors:  Constanze Buhrmann; Aranka Brockmueller; Choudhary Harsha; Ajaikumar B Kunnumakkara; Peter Kubatka; Bharat B Aggarwal; Mehdi Shakibaei
Journal:  Front Pharmacol       Date:  2021-07-02       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.